Work

Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19

Year: 2020

Type: article

Abstract: This case-control study examines the association between receipt of the bradykinin 2 (B2) receptor antagonist icatibant and improved oxygenation in patients with coronavirus disease 2019 (COVID-19).

Source: JAMA Network Open

DOI: 10.1001/jamanetworkopen.2020.17708

Authors: Frank L. van de Veerdonk, Ilse J. E. Kouijzer, Aline H. de Nooijer, Hans G. van der Hoeven, Coen Maas, Mihai G. Netea, Roger J. M. Brüggemann

Institutions: Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, University Medical Center Utrecht, University of Bonn, Radboud Institute for Health Sciences

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

OpenAlex ID: W3048929918

FWCI: 1.949

Cites: 3

Cited by: 63

Related to: 10